QCR Holdings (QCRH) executive reports performance share grant and exercise

Rhea-AI Filing Summary

QCR Holdings executive Laura L. Ekizian, President & CEO of QCBT, reported equity awards and an option exercise. She acquired 718 performance shares through a grant on March 2, 2026, and on March 1, 2026 she exercised 100 performance shares, receiving 73 common shares at $53.31 per share. Following these transactions, she directly holds 6,025 common shares and also reports 9,919 common shares held indirectly through a managed account. Footnotes state that related restricted stock units vest in four equal annual installments beginning on March 1, 2024 and March 2, 2027.

Insider Trade Summary

100 shares exercised/converted

Mixed 4 txns

Insider Ekizian Laura L

Role President & CEO, QCBT

Type	Security	Shares	Price	Value
Grant/Award	Performance Shares	718	$0.00	--
Exercise	Performance Shares	100	$0.00	--
Exercise	Common Stock	73	$53.31	$4K
holding	Common Stock	--	--	--

Holdings After Transaction: Performance Shares — 718 shares (Direct); Common Stock — 6,025 shares (Direct); Common Stock — 9,919 shares (Indirect, by Managed Account)

Footnotes (1)

1. Represents a restricted stock unit grant. Each restricted stock unit represents a contingent right to receive one share of QCR Holdings, Inc. common stock or the cash equivalent of one share of common stock. The restricted stock units vest in four annual equal installments beginning on March 1, 2024. Represents a restricted stock unit grant. Each restricted stock unit represents a contingent right to receive one share of QCR Holdings, Inc. common stock or the cash equivalent of one share of common stock. The restricted stock units vest in four annual equal installments beginning on March 2, 2027.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ekizian Laura L

(Last) (First) (Middle)

3551 SEVENTH STREET

SUITE 204

(Street)

MOLINE IL 61265

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QCR HOLDINGS INC [ QCRH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO, QCBT

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		M		73	A	$53.31	6,025	D
Common Stock								9,919	I	by Managed Account

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Shares	$53.31	03/01/2026		M			100	03/01/2024(1)	03/01/2027	Common Stock	100	$0.0	100	D
Performance Shares	$87.99	03/02/2026		A		718(2)		03/02/2027	03/02/2030	Common Stock	718	$0.0	718	D

Explanation of Responses:

1. Represents a restricted stock unit grant. Each restricted stock unit represents a contingent right to receive one share of QCR Holdings, Inc. common stock or the cash equivalent of one share of common stock. The restricted stock units vest in four annual equal installments beginning on March 1, 2024.

2. Represents a restricted stock unit grant. Each restricted stock unit represents a contingent right to receive one share of QCR Holdings, Inc. common stock or the cash equivalent of one share of common stock. The restricted stock units vest in four annual equal installments beginning on March 2, 2027.

	By: Shellee Showalter For: Laura Ekizian	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did QCRH executive Laura Ekizian report on this Form 4?

Laura Ekizian reported equity awards and an exercise. She received 718 performance shares in a grant and exercised 100 performance shares into 73 shares of QCR Holdings common stock, all recorded as acquisitions rather than open-market purchases or sales.

How many performance shares did Laura Ekizian acquire in the latest QCRH filing?

Laura Ekizian acquired 718 performance shares by grant. In addition, she exercised 100 performance shares in a separate transaction. These derivative awards are part of her equity-based compensation and increase her potential ownership tied to QCR Holdings’ future performance.

What price was used when Laura Ekizian received QCRH common stock from exercising performance shares?

The exercise delivered common stock at $53.31 per share. On March 1, 2026, 100 performance shares were exercised, resulting in 73 QCR Holdings common shares at a stated price of $53.31 per share in the Form 4 transaction detail.

How many QCRH common shares does Laura Ekizian hold directly and indirectly after these transactions?

Direct holdings total 6,025 common shares. The Form 4 also reports 9,919 QCR Holdings common shares held indirectly through a managed account, reflecting additional economic exposure separate from her directly owned share position.

What do the restricted stock unit footnotes in the QCRH Form 4 indicate?

The footnotes describe restricted stock unit grants. Each unit represents a right to one QCR Holdings common share or cash equivalent, vesting in four equal annual installments beginning on March 1, 2024, and March 2, 2027, respectively, subject to the grant terms.

Does the QCRH Form 4 show any insider sales by Laura Ekizian?

No insider sales are reported in this Form 4. All listed transactions are categorized as acquisitions, including a performance share grant and an exercise of derivative securities, with no open-market or other dispositions disclosed in the summary data.